Organisations from six countries including Sony, Philips, EV Group and Halma came together in Cambridge to launch the 3rd annual cycle of the Microfluidics Consortium.
International Microfluidics Consortium launches in Cambridge
The consortium has the mission to grow the market for microfluidics-enabled solutions to "grand challenges" such as point of care diagnostics, high throughput screening and novel chemical synthesis.
The consortium which is organised by the Centre for Business Innovation (CfBI) heard from speakers representing: NICE (National Institute for Health and Clinical Excellence); NHS Commissioning Alliance; Wellcome Trust Sanger Institute, Department of Chemistry, Institute of Biotechnology and Sphere Fluidics.
In working sessions (see photo) it addressed standards for microfluidic devices as well as focus for its upcoming meetings in Europe and the USA.
Its next meeting will be hosted by Johnson and Johnson at their Personalized Medicine centre of excellence in Belgium.
Dr Peter Hewkin who manages the consortium tells us "We are delighted with the way that the influence of the Microfluidics Consortium has grown and excited by the opportunity which it provides to push against the current fragmentation in the diagnostics and screening industries. This in turn will drive down the costs of important healthcare solutions."
The Centre for Business Innovation (CfBI) creates 'Connected Communities' which deliver 'Collaborative Advantage' for the benefit of their participants.